Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Suspension of Olympic Hopeful Sha'Carri Richardson Condemned by Athletes, Highlights Archaic Cannabis Rules

Athletes for CARE Expresses Support to Athlete Stripped of Opportunity to Represent United States in 100m Race at Tokyo Olympics


News provided by

Athletes for CARE

Jul 03, 2021, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Athletes for CARE Expresses Support to Athlete Stripped of Opportunity to Represent United States in 100m Race at Tokyo Olympics
Athletes for CARE Expresses Support to Athlete Stripped of Opportunity to Represent United States in 100m Race at Tokyo Olympics
Youtube
Youtube

JACKSONVILLE, Fla., July 3, 2021 /PRNewswire-PRWeb/ -- Athletes for CARE ("A4C"), a not-for-profit organization that advocates for the removal of stigma and punitive actions against the use of cannabis in sport, announces its unequivocal support for Sha'Carri Richardson in wake of her recent suspension from competition, and again calls on WADA and USADA to remove antiquated punitive actions against athletes who use cannabis.

Sha'Carri's month-long suspension for cannabis use immediately crushes her ability to compete in the 100m race at the Tokyo Olympics, in which she was expected to medal. The timing of the suspension keeps open the possibility that she will compete in the 4x100m relay, but relies on being chosen by USA Track and Field as one of two alternative runners.

Marvin Washington, A4C Co-founder and former NFL athlete, states that “WADA allows CBD but not THC - same plant - and neither are a performance enhancing substance. Let her run.”

Post this

Joanna Zeiger, Olympian, former triathlon world champion, and A4C Athlete Ambassador, comments, "THC is a tricky compound for two reasons. First, from an anti-doping perspective, THC is considered a threshold drug that can only be used out of competition; THC can be found in the blood up to a certain level before triggering a positive result. It is unknown how much THC needs to be consumed to reach this threshold and this amount is likely variable between individuals. This makes dosing incredibly difficult, particularly for athletes who are using cannabis to treat medical conditions." She continues, "a study on self-identified community based athletes found that 70% of current cannabis users slept better, 54% had decreased anxiety, and 58% stated that cannabis calmed them down," especially pertinent given Sha'Carri's mental state during the qualifiers in Oregon.

Anna Symonds, A4C Athlete Ambassador and long-time cannabis advocate, remarked, "It's an unfair and nonsense rule that has led to this injustice. USADA's and WADA's ban on THC during 'in-competition' windows is based on outdated and totally unscientific political biases, not real medical data. If these rules were truly a concern about "athlete health," then alcohol (a much more harmful substance) would also be banned in-competition – but it's not." She continues, "It is heart wrenching to see this electric young star be stripped of this singular opportunity. Cannabis doesn't meet WADA's own criteria for a banned substance, and it simply shouldn't be banned or tested for at all."

Marvin Washington, A4C Co-founder and former NFL athlete, states that "WADA allows CBD but not THC - same plant - and neither are a performance enhancing substance. Let her run."

Elias Theodorou, A4C Athlete Ambassador and UFC veteran, explains, "My journey to receive a Therapeutic Use Exemption ("TUE") for medical cannabis in North America was the hardest fight of my life. Athletes shouldn't need to jump through hoops to consume a non-performance-enhancing plant that is legal in many jurisdictions." Theodorou was recently the first professional athlete to receive a TUE to compete in the state of Colorado.

A4C welcomes athletes to join in advocacy at Athletes for CARE, and for everyone to sign the petition to WADA.

About Athletes for CARE (A4C)

Athletes for CARE (A4C) is a not-for-profit organization launched in 2017 by passionate retired professional athletes who recognized the need to advocate for the health, safety and wellness of more than 2 billion people of all ages who compete annually in sanctioned sports globally. Through that advocacy, we are improving health and wellness options for the billions of people around the world living with mental and physical illnesses including chronic pain, depression, anxiety, PTSD, CTE, TBI, substance abuse and opioid dependency. For more information, please visit athletesforcare.org.

For Further Information, Or media requests:
Jess Moran
Volunteer Marketing Director, A4C
Principal & Founder, JESSCO
519-494-5379
[email protected]

Media Contact

A4C, Athletes for CARE, 5194945379, [email protected]

SOURCE Athletes for CARE

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.